These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4897544)

  • 1. Antibody response and reactions to aqueous influenza vaccine, simple emulsion vaccine and multiple emulsion vaccine. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Taylor PJ; Miller CL; Pollock TM; Perkins FT; Westwood MA
    J Hyg (Lond); 1969 Sep; 67(3):485-90. PubMed ID: 4897544
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant influenza vaccines.
    Stuart-Harris CH
    Bull World Health Organ; 1969; 41(3):617-21. PubMed ID: 5309486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions.
    SALK JE; LAURENT AM
    J Exp Med; 1952 May; 95(5):429-47. PubMed ID: 14927797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water in-oil emulsion.
    SALK JE; BAILEY ML; LAURENT AM
    Am J Hyg; 1952 May; 55(3):439-56. PubMed ID: 14933383
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of a novel oil-in-water emulsion adjuvant for swine influenza virus and Mycoplasma hyopneumoniae vaccines.
    Galliher-Beckley A; Pappan LK; Madera R; Burakova Y; Waters A; Nickles M; Li X; Nietfeld J; Schlup JR; Zhong Q; McVey S; Dritz SS; Shi J
    Vaccine; 2015 Jun; 33(25):2903-8. PubMed ID: 25936722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.
    Chada KE; Forshee R; Golding H; Anderson S; Yang H
    Vaccine; 2017 May; 35(24):3162-3170. PubMed ID: 28483200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CLINICAL TRIALS OF OIL-ADJUVANT INFLUENZA VACCINES, 1960-3. REPORT TO THE MEDICAL RESEARCH COUNCIL BY ITS COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    UJHAZY V
    Br Med J; 1964 Aug; 2(5404):267-71. PubMed ID: 14160206
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
    Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
    BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN
    J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEROLOGICAL STUDIES ON ADULT VOLUNTEERS INOCULATED WITH OIL-ADJUVANT ASIAN INFLUENZA VACCINE. REPORT TO THE M.R.C. COMMITTEE ON INFLUENZA AND OTHER RESPIRATORY VIRUS VACCINES.
    HOBSON D; LANE CA; BEARE AS; CHIVERS CP
    Br Med J; 1964 Aug; 2(5404):271-4. PubMed ID: 14160207
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
    J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Tyrrell DA; Buckland R; Rubenstein D; Sharpe DM
    J Hyg (Lond); 1970 Sep; 68(3):359-68. PubMed ID: 4917914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.
    Treanor JJ; Essink B; Hull S; Reed S; Izikson R; Patriarca P; Goldenthal KL; Kohberger R; Dunkle LM
    Vaccine; 2013 Nov; 31(48):5760-5. PubMed ID: 24075920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines.
    Beare AS; Tyrrell DA; Hobson D; Howells CH; Pereira MS; Pollock TM; Tyler LE
    J Hyg (Lond); 1969 Mar; 67(1):1-11. PubMed ID: 5278156
    [No Abstract]   [Full Text] [Related]  

  • 15. Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial.
    Treanor JJ; Chu L; Essink B; Muse D; El Sahly HM; Izikson R; Goldenthal KL; Patriarca P; Dunkle LM
    Vaccine; 2017 Feb; 35(6):923-928. PubMed ID: 28089141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience in the United Kingdom with oil adjuvant influenza vaccines.
    Perkins FT
    Ann Allergy; 1972 May; 30(5):288-91. PubMed ID: 5063341
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.
    Deng J; Cai W; Jin F
    Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant.
    Stavaru C; Onu A; Lupulescu E; Tucureanu C; Rasid O; Vlase E; Coman C; Caras I; Ghiorghisor A; Berbecila L; Tofan V; Bowen RA; Marlenee N; Hartwig A; Bielefeldt-Ohmann H; Baldwin SL; Van Hoeven N; Vedvick TS; Huynh C; O'Hara MK; Noah DL; Fox CB
    Hum Vaccin Immunother; 2016 Apr; 12(4):1009-26. PubMed ID: 26618392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emulsion-based adjuvants for influenza vaccines.
    Vogel FR; Caillet C; Kusters IC; Haensler J
    Expert Rev Vaccines; 2009 Apr; 8(4):483-92. PubMed ID: 19348563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Hobson D; Baker FA; Curry RL; Beare AS; Massey PM
    J Hyg (Lond); 1973 Dec; 71(4):641-7. PubMed ID: 4588772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.